Kathleen R Cho Selected Research

TCF Transcription Factors

1/2010	IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.
6/2003	Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
6/2002	Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
4/2002	Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.
3/2002	ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen R Cho Research Topics

Disease

41	Neoplasms (Cancer) 01/2021 - 03/2002
17	Carcinoma (Carcinomatosis) 01/2022 - 04/2002
14	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 04/2002
13	Endometrioid Carcinoma 01/2020 - 04/2002
7	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2019 - 03/2002
7	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 11/2002
5	Carcinogenesis 11/2015 - 07/2003
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2015 - 08/2005
4	Adenoma (Adenomas) 10/2017 - 01/2005
4	Colonic Neoplasms (Colon Cancer) 11/2015 - 04/2002
3	Adenocarcinoma 03/2009 - 08/2002
2	Ovarian Epithelial Carcinoma 01/2021 - 07/2003
2	Neoplasm Metastasis (Metastasis) 07/2015 - 08/2005
2	Adenomatous Polyps 03/2012 - 09/2011
1	Inflammation (Inflammations) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022
1	Endometriosis 01/2022
1	Cysts 10/2019
1	Lymphatic Metastasis 12/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2015
1	Virilism (Virilization) 03/2012
1	Hyperplasia 09/2011
1	Polyps 09/2011
1	Acinar Cell Carcinoma 11/2010
1	Lipoma (Lipomata) 04/2008
1	Aneuploidy (Aneuploid) 10/2007
1	Squamous Intraepithelial Lesions 08/2005
1	Breast Neoplasms (Breast Cancer) 06/2005

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2019 - 03/2002
11	beta CateninIBA 01/2010 - 03/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2003
5	Biological ProductsIBA 10/2019 - 08/2002
5	TCF Transcription FactorsIBA 01/2010 - 03/2002
4	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2008 - 03/2002
4	OligonucleotidesIBA 11/2007 - 08/2002
3	Calcibiotic Root Canal SealerIBA 10/2019 - 09/2011
3	CateninsIBA 11/2015 - 03/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 04/2003
3	RNA (Ribonucleic Acid)IBA 01/2013 - 07/2003
2	Hormones (Hormone)IBA 01/2022 - 01/2020
2	ChromatinIBA 01/2020 - 01/2017
2	TOR Serine-Threonine KinasesIBA 04/2013 - 11/2010
2	Sirolimus (Rapamycin)FDA Link 12/2011 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 11/2006 - 07/2003
2	CollagenIBA 08/2005 - 04/2003
2	Tumor Biomarkers (Tumor Markers)IBA 08/2004 - 10/2003
1	SmokeIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Oral ContraceptivesIBA 01/2022
1	Talc FDA Link 01/2022
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2021
1	Combined Oral ContraceptivesIBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 01/2021
1	Progestins (Progestagens)IBA 01/2021
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	mahuang-tangIBA 01/2020
1	TubulinIBA 10/2019
1	Mutant Proteins (Protein, Mutant)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 11/2015
1	ParaffinIBA 11/2015
1	Bevacizumab (Avastin)FDA Link 04/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	PlatinumIBA 01/2013
1	SteroidsIBA 03/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2011
1	API 2IBA 12/2011
1	perifosineIBA 12/2011
1	N- succinimidyl- 3- (4- hydroxyphenyl)propionate (HPPS)IBA 09/2011
1	Estrogen Receptor alphaIBA 08/2010
1	NF-kappa B (NF-kB)IBA 06/2010
1	Transcription Factors (Transcription Factor)IBA 06/2010
1	VimentinIBA 03/2009
1	Lamin Type A (Lamin A)IBA 03/2009
1	Neurofibromin 1 (Neurofibromin)IBA 12/2008
1	Guanosine Triphosphate (GTP)IBA 12/2008
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2008
1	Homeodomain Proteins (Proteins, Homeobox)IBA 11/2007
1	Small Interfering RNA (siRNA)IBA 11/2007
1	Cre recombinaseIBA 10/2007
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 01/2007
1	Fibroblast Growth Factor 9IBA 02/2006
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2005
1	Tissue Inhibitor of Metalloproteinase-2IBA 08/2005
1	EnzymesIBA 08/2005
1	ElementsIBA 01/2005
1	ProteomeIBA 08/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 07/2003
2	Immunotherapy 01/2021 - 01/2020
1	Injections 01/2021
1	Cystectomy 03/2015
1	Ovariectomy (Oophorectomy) 03/2015
1	Radiotherapy 03/2013
1	Drug Therapy (Chemotherapy) 01/2013
1	Colectomy 03/2012